» Articles » PMID: 28560557

Heterogeneity Among Neutrophils

Overview
Publisher Sciendo
Date 2017 Jun 1
PMID 28560557
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Neutrophils (PMNs) play a key role in innate defence mechanisms. Generally, PMNs were considered to have a homogeneous population of mature and diversified cells. It seems, however, that their pleiotropic action results from the existence of different subpopulations in this group of cells. There are data that confirm the involvement of PMNs in the direct activation of other cells in non-specific response, as well as specialised cells in specific response. For example, there have been observations of PMNs with different levels of activity in relation to lymphocytes, and a population was identified which had characteristics similar to those of cells which are capable of presenting antigens. There are also reports of PMNs which demonstrate different survival time or capacity for chemotaxis. Other studies suggest that the neutrophil response to Staphylococcus aureus is diverse (not identical among all neutrophil). There are also reports of PMNs with varying activity during inflammation, which might explain many as yet unknown pathophysiological aspects of their hyperreactivity. The functional dualism of PMNs in the course of neoplastic disorders raises a lot of controversy. This paper presents the current state of knowledge of the heterogeneity of PMNs and their potential roles in different stages of disease.

Citing Articles

Clustering analyses of murine bone marrow-derived neutrophils reveal a phenotypic heterogeneity that can respond differentially to stimulation.

Silva P, Penaloza H, Cordero J, Kalergis A, Barrera N, Bueno S Heliyon. 2025; 11(4):e42227.

PMID: 40040995 PMC: 11876930. DOI: 10.1016/j.heliyon.2025.e42227.


CD206+ Trem2+ macrophage accumulation in the murine knee joint after injury is associated with protection against post-traumatic osteoarthritis in MRL/MpJ mice.

McCool J, Sebastian A, Hum N, Wilson S, Davalos O, Murugesh D PLoS One. 2025; 20(1):e0312587.

PMID: 39752388 PMC: 11698337. DOI: 10.1371/journal.pone.0312587.


The granulocyte colony-stimulating factor produced during infection controls neutrophil recruitment in the blood without affecting bacterial clearance.

Bleuze M, Lehoux M, Auger J, Gottschalk M, Segura M Front Immunol. 2024; 15:1403789.

PMID: 39156897 PMC: 11327821. DOI: 10.3389/fimmu.2024.1403789.


Harnessing natural killer cells for refractory/relapsed non-Hodgkin lymphoma: biological roles, clinical trials, and future prospective.

Bakhtiyaridovvombaygi M, Yazdanparast S, Kheyrandish S, Safdari S, Amiri Samani F, Sohani M Biomark Res. 2024; 12(1):66.

PMID: 39020411 PMC: 11253502. DOI: 10.1186/s40364-024-00610-z.


Exploring the function of myeloid cells in promoting metastasis in head and neck cancer.

Okwuone D, Morgan D, Gan G Explor Target Antitumor Ther. 2024; 5(1):108-119.

PMID: 38468824 PMC: 10925485. DOI: 10.37349/etat.2024.00208.


References
1.
Kusmartsev S, Su Z, Heiser A, Dannull J, Eruslanov E, Kubler H . Reversal of myeloid cell-mediated immunosuppression in patients with metastatic renal cell carcinoma. Clin Cancer Res. 2008; 14(24):8270-8. DOI: 10.1158/1078-0432.CCR-08-0165. View

2.
Gorgun G, Whitehill G, Anderson J, Hideshima T, Maguire C, Laubach J . Tumor-promoting immune-suppressive myeloid-derived suppressor cells in the multiple myeloma microenvironment in humans. Blood. 2013; 121(15):2975-87. PMC: 3624943. DOI: 10.1182/blood-2012-08-448548. View

3.
Granot Z, Jablonska J . Distinct Functions of Neutrophil in Cancer and Its Regulation. Mediators Inflamm. 2015; 2015:701067. PMC: 4663337. DOI: 10.1155/2015/701067. View

4.
Casanova-Acebes M, Pitaval C, Weiss L, Nombela-Arrieta C, Chevre R, A-Gonzalez N . Rhythmic modulation of the hematopoietic niche through neutrophil clearance. Cell. 2013; 153(5):1025-35. PMC: 4128329. DOI: 10.1016/j.cell.2013.04.040. View

5.
Jiang J, Guo W, Liang X . Phenotypes, accumulation, and functions of myeloid-derived suppressor cells and associated treatment strategies in cancer patients. Hum Immunol. 2014; 75(11):1128-37. DOI: 10.1016/j.humimm.2014.09.025. View